X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/04/11/2644128/0/en/Australia-s-Paradigm-Biopharmaceuticals-says-phase-2-trial-in-osteoarthritis-shows-signs-of-disease-modification-at-6-month-follow-up.html
https://www.fiercebiotech.com/cro/paradigm-debuts-203m-series-funding-focused-trial-platform-patient-diversity
https://www.prnewswire.com/news-releases/paradigm-achieves-primary-endpoint-in-paraoa008-synovial-fluid-biomarker-phase-2-clinical-trial-301640478.html
https://www.prnewswire.com/news-releases/paradigm-partners-with-nfl-alumni-health-on-osteoarthritis-program-301587025.html
https://www.proactiveinvestors.com.au/companies/news/986695/paradigm-biopharmaceuticals-begins-uk-based-screening-for-phase-3-study-assessing-zilosul-on-knee-oa-986695.html
https://www.prnewswire.com/news-releases/paradigm-biopharmaceuticals-ltd-appoints-marco-polizzi-as-chief-executive-officer-301576040.html
https://www.prnewswire.com/news-releases/paradigm-biopharmaceuticals-retains-rubenstein-public-relations-as-agency-of-record-301528262.html
https://www.prnewswire.com/news-releases/fda-grants-fast-track-designation-for-paradigm-biopharmaceuticals-phase-iii-osteoarthritis-program-301525079.html
https://www.prnewswire.com/news-releases/paradigm-biopharmaceuticals-initiates-a-phase-3-clinical-trial-in-knee-osteoarthritis-across-the-us-301505255.html
https://www.proactiveinvestors.com.au/companies/news/963000/paradigm-biopharmaceuticals-releases-positive-top-line-preclinical-study-results-for-pps-treatment-in-acute-respiratory-distress-syndrome-963000.html
Market Place
Share 
